- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Small Cell and Non-small Cell Lung Cancer in Canada
Total 1229 results
-
Centre de Recherche de l'Institut Universitaire...CHU de Quebec-Universite LavalWithdrawnSurgery | Non-small Cell Lung Cancer Stage I | Stereotactic Body Radiation TherapyCanada
-
Bristol-Myers SquibbCompletedNon-small Cell Lung CancerCanada, United States
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lunch CancerItaly, United States, Germany, Spain, Canada
-
Cell>Point LLCVenn Life Sciences; Numoda; Camargo Pharmaceutical Services; Biomedical ServicesCompletedNon Small Cell Lung CancerUnited States, Canada
-
Canadian Cancer Trials GroupOncolytics BiotechCompletedNon Small Cell Lung CancerCanada
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small Cell | Non-Small-Cell Lung CancerUnited States, Canada, Poland
-
AHS Cancer Control AlbertaCross Cancer InstituteTerminatedNon-small Cell Lung Cancer | Advanced Solid MalignanciesCanada
-
AstraZenecaRecruiting
-
Spanish Lung Cancer GroupCompletedNon-small-cell Lung CancerSpain
-
Peter MacCallum Cancer Centre, AustraliaCompletedNon-small Cell Lung CancerAustralia, Canada
-
British Columbia Cancer AgencyRecruitingNon Small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal MetastasisCanada
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Spain, Switzerland, United Kingdom
-
YM BioSciencesCIMYM BioSciencesTerminatedNon-small-cell Lung CancerCanada, United States, Singapore
-
Bristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States, Canada
-
Millennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States, Netherlands, Canada
-
Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term CareCompletedNon-small-cell Lung CarcinomaCanada
-
Spanish Lung Cancer GroupCompletedNon Small Cell Lung CancerSpain
-
Fundación GECPRecruitingStage IIIA Non-small Cell Lung CancerSpain
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Fundación GECPActive, not recruiting
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
Achieve Life SciencesCompletedNon-small Cell Lung CancerUnited States, Canada
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerSpain, France, United States, Taiwan, Canada, Netherlands, Mexico
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Spanish Lung Cancer GroupCompletedNon Small Cell Lung CancerSpain
-
University of British ColumbiaAstraZeneca; Ozmosis Research Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Lung Cancer Stage I | Lung Adenocarcinoma, Stage I | Lung Squamous Cell Carcinoma Stage ICanada
-
Novartis PharmaceuticalsCompletedNon-small-cell Lung CancerCanada, France, Spain, Netherlands, Singapore, Germany, Korea, Republic of, Turkey, United States, Norway
-
PfizerCompletedNon-small Cell Lung CancerUnited States, France, Canada
-
AstraZenecaMedpace, Inc.CompletedNon-small Cell Lung CancerUnited States, Canada
-
Bristol-Myers SquibbCompletedNon-Small-Cell Lung CancerUnited States, Canada
-
Ontario Clinical Oncology Group (OCOG)Canadian Cancer Society (CCS)CompletedNon-small Cell Lung CancerCanada
-
University Health Network, TorontoAstraZenecaWithdrawnSquamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaCanada
-
PfizerTerminatedNon-small Cell Lung Cancer | Urothelial CancerSpain, Czechia, United States, Australia, United Kingdom, Italy, Canada, Hungary
-
AstraZenecaCompletedEGFR Mutated Non-small Cell Lung Cancer PatientsSpain
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerFrance, Spain, United States, Belgium, Netherlands, Canada, Italy, Singapore, Korea, Republic of, Czechia, Germany, Hong Kong
-
MedImmune LLCTerminatedNon-small Cell Lung CancerUnited States, Canada, Japan, Poland, Germany, Hungary, France
-
Synta Pharmaceuticals Corp.CompletedNon Small Cell Lung CancerUnited States, Canada
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
Geron CorporationCompletedNon-small Cell Lung CancerUnited States, Canada, Germany
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung CancerSpain, Belgium, France, Italy, Netherlands, Canada, United Kingdom, United States
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, China, Romania, Netherlands, Hong Kong, Austria, Belgium, Czechia, Hungary, Portugal, Greece, Germany, Ireland, Switze... and more
-
AmgenCompletedNon Small Cell Lung CancerUnited States, Canada, Australia, Spain, Belgium, Greece
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore